Screener
Quest Diagnostics DGX Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Quest Diagnostics in its filing.
Tagged under the XBRL concept us-gaap:EquityMethodInvestments.
The source filing: Quest Diagnostics’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001022079-26-000070
FAQ
- What is Quest Diagnostics's equity method investments?
- Quest Diagnostics (DGX) reported equity method investments of $137M in Q2 2026.
- How has Quest Diagnostics's equity method investments changed year-over-year?
- Quest Diagnostics's equity method investments increased by 0.7% year-over-year, from $136M to $137M.
- What is the long-term trend for Quest Diagnostics's equity method investments?
- Over 5 years (2020 to 2025), Quest Diagnostics's equity method investments has grown at a -23.6% compound annual growth rate (CAGR), from $521M to $136M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.
Ask your AI about Quest Diagnostics's equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude